NTSAD leads the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1, and Sandhoff diseases
by driving research, forging collaboration, and fostering community.
Supporting families is the center of everything we do.
Join us, learn more, and support our cause.
Enzyme Replacement Therapy (ERT) provides the missing or deficient enzyme through regular IV infusions. However, enzymes are large molecules that do not pass the blood brain barrier into the central nervous system. Approved ERT therapies are currently only effective for treating the non-neurological symptoms of diseases.